IBRX vs GOOGL: Which Stock is Better?

Side-by-side comparison of Immunitybio Inc and Alphabet Inc in 2026

Comparison Updated:

IBRX

Immunitybio Inc

$7.25

GOOGL

Alphabet Inc

$338.20

Key Metrics Comparison

MetricIBRXGOOGLWinner
Market Cap$8.03BN/AIBRX
P/E RatioN/A30.76GOOGL
EPS (TTM)$N/A$10.96GOOGL
Revenue Growth4.1%0.2%IBRX
Gross Margin99.3%59.7%IBRX

Analyze IBRX

Full quant analysis

Analyze GOOGL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IBRX or GOOGL a better investment?

Comparing IBRX and GOOGL: Immunitybio Inc has a market cap of $8.03B while Alphabet Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IBRX and GOOGL?

IBRX (Immunitybio Inc) and GOOGL (Alphabet Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IBRX or GOOGL?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IBRX or GOOGL?

IBRX has higher revenue growth at 4.1% vs 0.2% for GOOGL.

Which company is more profitable: IBRX or GOOGL?

Immunitybio Inc (IBRX) has higher gross margins at 99.3% compared to 59.7% for GOOGL.

Which is the larger company: IBRX or GOOGL?

Immunitybio Inc (IBRX) is larger with a market cap of $8.03B compared to N/A for GOOGL.

Should I buy IBRX or GOOGL in 2026?

Both IBRX and GOOGL have investment merit. IBRX trades at $7.25 while GOOGL trades at $338.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IBRX and GOOGL stock?

Key differences: Market Cap ($8.03B vs N/A), P/E Ratio (N/A vs 30.8x), Revenue Growth (4.1% vs 0.2%), Gross Margin (99.3% vs 59.7%).

Popular Stock Comparisons